Anna Melone

664 total citations
18 papers, 523 citations indexed

About

Anna Melone is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Anna Melone has authored 18 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Anna Melone's work include PI3K/AKT/mTOR signaling in cancer (10 papers), Quinazolinone synthesis and applications (3 papers) and Tuberous Sclerosis Complex Research (2 papers). Anna Melone is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (10 papers), Quinazolinone synthesis and applications (3 papers) and Tuberous Sclerosis Complex Research (2 papers). Anna Melone collaborates with scholars based in Switzerland, Italy and Germany. Anna Melone's co-authors include Matthias P. Wymann, Doriano Fabbro, Florent Beaufils, Denise Rageot, Alexander Sele, Petra Hillmann, Thomas Bohnacker, Paul Hebeisen, Chiara Borsari and Marketa Zvelebil and has published in prestigious journals such as Nature Communications, Cancer Research and Journal of Allergy and Clinical Immunology.

In The Last Decade

Anna Melone

16 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Melone Switzerland 11 337 165 57 51 47 18 523
Alexander Sele Switzerland 8 310 0.9× 168 1.0× 53 0.9× 49 1.0× 36 0.8× 10 456
Denise Rageot Switzerland 13 373 1.1× 269 1.6× 57 1.0× 53 1.0× 42 0.9× 19 640
Brian Metcalf United States 10 221 0.7× 136 0.8× 53 0.9× 25 0.5× 22 0.5× 18 578
Matthew C. Lucas United States 16 159 0.5× 220 1.3× 37 0.6× 18 0.4× 48 1.0× 32 530
Nicolas Warin United Kingdom 4 222 0.7× 111 0.7× 41 0.7× 27 0.5× 24 0.5× 7 394
Alexios-Leandros Skaltsounis Greece 3 523 1.6× 149 0.9× 24 0.4× 21 0.4× 39 0.8× 4 708
Lori K. Gavrin United States 8 218 0.6× 126 0.8× 24 0.4× 18 0.4× 32 0.7× 9 386
Joy Bauch United States 12 456 1.4× 172 1.0× 53 0.9× 58 1.1× 22 0.5× 20 751
Kristiina Nordfors Finland 11 404 1.2× 115 0.7× 124 2.2× 20 0.4× 15 0.3× 27 513
Annie Olivier France 10 262 0.8× 160 1.0× 28 0.5× 25 0.5× 24 0.5× 12 492

Countries citing papers authored by Anna Melone

Since Specialization
Citations

This map shows the geographic impact of Anna Melone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Melone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Melone more than expected).

Fields of papers citing papers by Anna Melone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Melone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Melone. The network helps show where Anna Melone may publish in the future.

Co-authorship network of co-authors of Anna Melone

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Melone. A scholar is included among the top collaborators of Anna Melone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Melone. Anna Melone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Melone, Anna, Christina Bauer, Michele Romano, et al.. (2024). Analytical Validation and Stability Studies for Basophil Activation Test to Meet IVDR Certification.. Journal of Allergy and Clinical Immunology. 153(2). AB30–AB30.
2.
3.
Villiger, Thomas K., Frank I. Bantleon, Anna Melone, et al.. (2021). Development of a Unique Rapid Test to Detect Anti-bodies Directed Against an Extended RBD of SARS-CoV-2 Spike Protein. CHIMIA International Journal for Chemistry. 75(5). 446–446. 2 indexed citations
4.
5.
6.
Borsari, Chiara, Denise Rageot, Thomas Bohnacker, et al.. (2019). A Conformational Restriction Strategy for the Identification of a Highly Selective Pyrimido-pyrrolo-oxazine mTOR Inhibitor. Journal of Medicinal Chemistry. 62(18). 8609–8630. 30 indexed citations
7.
Salvadori, Emilia, Anna Poggesi, Laura Tudisco, et al.. (2019). Association of nimodipine and choline alphoscerate in the treatment of cognitive impairment in patients with cerebral small vessel disease: study protocol for a randomized placebo-controlled trial—the CONIVaD trial. Aging Clinical and Experimental Research. 32(3). 449–457. 14 indexed citations
8.
Rageot, Denise, Thomas Bohnacker, Erhan Keleş, et al.. (2019). (S)-4-(Difluoromethyl)-5-(4-(3-methylmorpholino)-6-morpholino-1,3,5-triazin-2-yl)pyridin-2-amine (PQR530), a Potent, Orally Bioavailable, and Brain-Penetrable Dual Inhibitor of Class I PI3K and mTOR Kinase. Journal of Medicinal Chemistry. 62(13). 6241–6261. 49 indexed citations
9.
Borsari, Chiara, Denise Rageot, Florent Beaufils, et al.. (2019). Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl–Pyrimidine Moiety. ACS Medicinal Chemistry Letters. 10(10). 1473–1479. 34 indexed citations
10.
11.
12.
Bohnacker, Thomas, A.E. Prota, Florent Beaufils, et al.. (2017). Deconvolution of Buparlisib’s mechanism of action defines specific PI3K and tubulin inhibitors for therapeutic intervention. Nature Communications. 8(1). 14683–14683. 86 indexed citations
13.
Beaufils, Florent, Vladimir Cmiljanović, Thomas Bohnacker, et al.. (2017). 5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology. Journal of Medicinal Chemistry. 60(17). 7524–7538. 115 indexed citations
14.
Rageot, Denise, Florent Beaufils, Anna Melone, et al.. (2017). Abstract 140: Discovery and biological evaluation of PQR530, a highly potent dual pan-PI3K/mTORC1/2 inhibitor. Cancer Research. 77(13_Supplement). 140–140. 3 indexed citations
15.
Hillmann, Petra, Denise Rageot, Florent Beaufils, et al.. (2017). Abstract 159: Pharmacological characterization of the selective, orally bioavailable, potent dual PI3K/mTORC1/2 inhibitor PQR530. Cancer Research. 77(13_Supplement). 159–159. 3 indexed citations
16.
Cmiljanović, Vladimir, Robert A. Ettlin, Florent Beaufils, et al.. (2015). Abstract 4514: PQR309: A potent, brain-penetrant, dual pan-PI3K/mTOR inhibitor with excellent oral bioavailability and tolerability. Cancer Research. 75(15_Supplement). 4514–4514. 3 indexed citations
17.
Tarantelli, Chiara, Eugenio Gaudio, Ivo Kwee, et al.. (2015). Abstract 2652: Pre-clinical activity and mechanism of action of the novel dual PI3K/mTOR inhibitor PQR309 in B-cell lymphomas. Cancer Research. 75(15_Supplement). 2652–2652.
18.
Kiefer, Sabine, et al.. (2010). Separation and detection of all phosphoinositide isomers by ESI-MS. Journal of Pharmaceutical and Biomedical Analysis. 53(3). 552–558. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alexander Sele Breakdown of academic impact, for papers by Denise Rageot Breakdown of academic impact, for papers by Brian Metcalf Breakdown of academic impact, for papers by Matthew C. Lucas Breakdown of academic impact, for papers by Nicolas Warin Breakdown of academic impact, for papers by Alexios-Leandros Skaltsounis Breakdown of academic impact, for papers by Lori K. Gavrin Breakdown of academic impact, for papers by Joy Bauch Breakdown of academic impact, for papers by Kristiina Nordfors Breakdown of academic impact, for papers by Annie Olivier
Rankless by CCL
2026